Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
- 3 May 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 119 (18) , 4215-4223
Abstract
The prognostic role of the transcription factor SOX11 in mantle cell lymphoma (MCL) is controversial. We investigated prognostic markers in a population-based cohort of 186 MCL cases. Seventeen patients (9%) did not require any therapy within the first 2 years after diagnosis and were retrospectively defined as having an indolent disease. As expected, indolent MCL had less frequent B symptoms and extensive nodal involvement and 88% of these cases expressed SOX11. In our cohort 13 cases (7.5%) lacked nuclear SOX11 at diagnosis. SOX11− MCL had a higher frequency of lymphocytosis, elevated level of lactate dehydrogenase (LDH), and p53 positivity. The overall survival in the whole cohort, excluding 37 patients receiving autologous stem cell transplantation, was 3.1 year and in patients with indolent or nonindolent disease, 5.9 and 2.8 years, respectively (P = .004). SOX11− cases had a shorter overall survival, compared with SOX11+ cases, 1.5 and 3.2 years, respectively (P = .014). In multivariate analysis of overall survival, age > 65 (P = .001), Eastern Cooperative Oncology Group score ≥ 2 (P = .022), elevated LDH level (P = .001), and p53 expression (P = .001) remained significant, and SOX11 lost significance. We conclude that most indolent MCLs are SOX11+ and that SOX11 cannot be used for predicting an indolent disease course.Keywords
This publication has 40 references indexed in Scilit:
- The complex landscape of genetic alterations in mantle cell lymphomaSeminars in Cancer Biology, 2011
- Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosisHaematologica, 2011
- Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic eraBlood, 2011
- Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitorsNature Communications, 2010
- Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphomaHaematologica, 2009
- Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL NetworkJournal of Hematopathology, 2009
- Induction of SOX4 by DNA damage is critical for p53 stabilization and functionProceedings of the National Academy of Sciences of the United States of America, 2009
- The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular propertiesNucleic Acids Research, 2008
- Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factorsThe International Journal of Biochemistry & Cell Biology, 2007
- Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocationBritish Journal of Haematology, 1993